The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway.

MLA

Gao, Yan, et al. “The Active Ingredient of Evodia Rutaecarpa Reduces Inflammation in Knee Osteoarthritis Rats through Blocking Calcium Influx and NF‐κB Pathway.” Basic & Clinical Pharmacology & Toxicology, vol. 135, no. 6, Dec. 2024, pp. 705–19. EBSCOhost, https://doi.org/10.1111/bcpt.14096.

APA

Gao, Y., Wang, S., Gao, Y., & Yang, L. (2024). The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway. Basic & Clinical Pharmacology & Toxicology, 135(6), 705–719. https://doi.org/10.1111/bcpt.14096

Chicago

Gao, Yan, Sixiang Wang, Yuehong Gao, and Li Yang. 2024. “The Active Ingredient of Evodia Rutaecarpa Reduces Inflammation in Knee Osteoarthritis Rats through Blocking Calcium Influx and NF‐κB Pathway.” Basic & Clinical Pharmacology & Toxicology 135 (6): 705–19. doi:10.1111/bcpt.14096.